Click to Enlarge
Facebook
Twitter
The Times describes the drug as a “new era for Alzheimer’s”, with the charity Alzheimer’s Research UK telling the paper this could be the point at which the disease becomes “treatable”. There is also a report about the BBC facing a formal review into the future of the licence fee. A government source is reported to have said there is a “growing unwillingness to pay”.